High Vista Strategies LLC Pmv Pharmaceuticals, Inc. Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.23 - $22.43 $215,280 - $523,157	23,324 New	23,324 $332,000
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $591,086 - $936,748	-39,777 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.84 - $36.58 $429,949 - $585,975	16,019 Added 67.43%	39,777 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $80,668 - $103,708	2,880 Added 13.79%	23,758 $812,000
Q1 2021 May 17, 2021	SELL	$30.66 - $49.5 $54,452 - $87,912	-1,776 Reduced 7.84%	20,878 $687,000
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $721,756 - $1.39 Million	22,654 New	22,654 $1.39 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.